German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease

Conclusion: Superiority of DCB over PTA in the German cohort of LEVANT 2 was demonstrated for primary patency, composite safety, and freedom from TLR. The benefit of DCB was also consistent for both genders. Geographic or regional differences in procedural variables may account for the different outcomes between the German and non-German cohorts.

Source: Journal of Endovascular Therapy - May 10, 2016 Category: Surgery Authors: Scheinert, D., Schmidt, A., Zeller, T., Müller-Hülsbeck, S., Sixt, S., Schröder, H., Weiss, N., Ketelsen, D., Ricke, J., Steiner, S., Rosenfield, K. Tags: Lower Limb Interventions Source Type: research